Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention

Published: November 30, 2020

Ethnic woman in medical consultation with female doctor
  • This scientific statement is intended to raise awareness of the significant adverse cardio-metabolic health-related changes accompanying midlife and the menopause transition (MT).
  • New findings on menopause and cardiovascular disease (CVD) risk have emerged since the AHA published Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update; the new information should be considered.
  • This statement expands on the 2011 guideline by providing updated, detailed information specific to MT and CVD in women.